# FDA recall D-0005-2022

> **RISING PHARMACEUTICALS** · Class II · drug recall initiated 2021-09-02.

## Product

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01

## Reason for recall

Labeling: Incorrect Instructions

## Distribution

to be entered

## Key facts

- **Recall number:** D-0005-2022
- **Recalling firm:** RISING PHARMACEUTICALS
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2021-09-02
- **Report date:** 2021-10-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0005-2022

## Citation

> AI Analytics. FDA recall D-0005-2022. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0005-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*